R20 rechargeable sacral neuromodulation | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 8,909 条关于 “R20 rechargeable sacral neuromodulation”

Axonics R20 Sacral Neuromodulation System Gains Australian Regulatory Approval

FDA Approves First Integrated Sacral Neuromodulation System for Urinary Urge Incontinence

Battery-Free Sacral Neuromodulation Device Shows 84% Success Rate in Treating Urinary Incontinence

Boomerang Medical Secures $20M Series B to Advance First Pivotal Neuromodulation Trial for Ulcerative Colitis

Batteryless Neurostimulator Shows Promising 6-Month Results for Overactive Bladder Treatment

SetPoint Medical Seeks FDA Approval for Novel Neuromodulation Device in Rheumatoid Arthritis

NinaMED Secures $13.75M to Advance Non-Invasive Overactive Bladder Therapy Targeting 550 Million Patients

Ring 20 Syndrome: Ultra-Rare Epilepsy Faces Diagnostic Challenges in Era of Modern Gene Sequencing

SetPoint Medical's Vagus Nerve Stimulation Device Receives FDA IDE for Multiple Sclerosis Trial

Salvia raises $60M for neuromodulation migraine system

第 1 页，共 50 页